Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
332
-
Total 13F shares, excl. options
-
85M
-
Shares change
-
+1.1M
-
Total reported value, excl. options
-
$9.5B
-
Value change
-
+$181M
-
Put/Call ratio
-
1.08
-
Number of buys
-
175
-
Number of sells
-
-140
-
Price
-
$111.78
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q3 2020
385 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q3 2020.
Guardant Health, Inc. - Common Stock (GH) has 332 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85M shares
of 124M outstanding shares and own 68.62% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (14M shares), VANGUARD GROUP INC (6.53M shares), MORGAN STANLEY (6.31M shares), BlackRock Inc. (4.99M shares), VIKING GLOBAL INVESTORS LP (3.85M shares), Clearbridge Investments, LLC (3.3M shares), JENNISON ASSOCIATES LLC (3.18M shares), Nuveen Asset Management, LLC (2.88M shares), Capital Research Global Investors (1.99M shares), and FRED ALGER MANAGEMENT, LLC (1.94M shares).
This table shows the top 332 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.